Skip to main content

Advertisement

SpringerLink
Log in

Diagnosis and treatment of the neuromuscular manifestations of Lyme disease

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Although estimates vary, the nervous system appears to be involved in 10% to 15% of patients infected with Borrelia burgdorferi. The resulting disorders, known collectively as neuroborreliosis or nervous system Lyme disease, generally respond well to antimicrobial therapy. Definitive treatment of nervous system infection typically consists of 2 to 4 weeks of parenteral ceftriaxone, cefotaxime, or high-dose penicillin (Class III). However, numerous European studies have shown that oral doxycycline is equally effective in patients with Lyme meningitis and cranial neuritis (Class II and III). This may be equally valid in patients infected with the strains prevalent in the United States, but this remains to be established.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Ceftriaxone-associated biliary complications of treatment of suspected disseminated Lyme disease—New Jersey, 1990–1992. MMWR Morb Mortal Wkly Rep 1993, 42:39–42.

  2. Garin C, Bujadoux A: Paralysie par les tiques. J Med Lyon 1922, 71:765–767.

    Google Scholar 

  3. Burgdorfer W, Barbour AG, Hayes SF, et al.: Lyme disease: a tick borne spirochetosis? Science 1982, 216:1317–1319.

    Article  PubMed  CAS  Google Scholar 

  4. Hellerstrom S: Erythema migrans Afzelius with meningitis. Acta Derm Venereol (Stockholm) 1951, 31:227–234.

    CAS  Google Scholar 

  5. Halperin JJ, Luft BJ, Volkman DJ, Dattwyler RJ: Lyme neuroborreliosis—peripheral nervous system manifestations. Brain 1990, 113:1207–1221.

    Article  PubMed  Google Scholar 

  6. Wormser GP, Dattwyler RJ, Shapiro ED, et al.: The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006, 43:1089–1134.

    Article  PubMed  Google Scholar 

  7. Halperin JJ, Shapiro ED, Logigian EL, et al.: Practice parameter: treatment of nervous system Lyme disease. Neurology 2007, In press.

  8. Rand PW, Lubelczyk C, Holman MS, et al.: Abundance of Ixodes scapularis (Acari: Ixodidae) after the complete removal of deer from an isolated offshore island, endemic for Lyme disease. J Med Entomol 2004, 41:779–784.

    Article  PubMed  Google Scholar 

  9. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep 1997, 46:1–55.

    Google Scholar 

  10. Gerber MA, Shapiro ED, Burke GS, et al.: Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med 1996, 335:1270–1274.

    Article  PubMed  CAS  Google Scholar 

  11. Steere AC, Sikand VK: The presenting manifestations of Lyme disease and the outcomes of treatment. N Engl J Med 2003, 348:2472–2474.

    Article  PubMed  Google Scholar 

  12. Steere AC, Malawista SE, Hardin JA, et al.: Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med 1977, 86:685–698.

    PubMed  CAS  Google Scholar 

  13. Lyme disease—United States, 2001–2002. MMWR Morb Mortal Wkly Rep 2004, 53:365–369.

    Google Scholar 

  14. Reik L, Steere AC, Bartenhagen NH, et al.: Neurologic abnormalities of Lyme disease. Medicine 1979, 58:281–294.

    Article  PubMed  CAS  Google Scholar 

  15. Skogman BH, Croner S, Odkvist L: Acute facial palsy in children—a 2-year follow-up study with focus on Lyme neuroborreliosis. Int J Pediatr Otorhinolaryngol 2003, 67:597–602.

    Article  PubMed  Google Scholar 

  16. Kalina P, Decker A, Kornel E, Halperin JJ: Lyme disease of the brainstem. Neuroradiology 2005, 47:903–907.

    Article  PubMed  Google Scholar 

  17. Halperin J, Logigian E, Finkel M, Pearl R: Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Neurology 1996, 46:619–627.

    PubMed  CAS  Google Scholar 

  18. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995, 44:590–591.

  19. Peltomaa M, McHugh G, Steere AC: The VlsE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis. Otol Neurotol 2004, 25:838–841.

    Article  PubMed  Google Scholar 

  20. Dressler F, Whalen JA, Reinhardt BN, Steere AC: Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993, 167:392–400.

    PubMed  CAS  Google Scholar 

  21. Halperin JJ: Lyme disease and the peripheral nervous system. Muscle Nerve 2003, 28:133–143.

    Article  PubMed  Google Scholar 

  22. Eiffert H, Karsten A, Schlott T, et al.: Acute peripheral facial palsy in Lyme disease—a distal neuritis at the infection site. Neuropediatrics 2004, 35:267–273.

    Article  PubMed  CAS  Google Scholar 

  23. Halperin JJ: Facial nerve palsy associated with Lyme disease. Muscle Nerve 2003, 28:516–517.

    Article  PubMed  Google Scholar 

  24. Sibony P, Halperin J, Coyle P, Patel K: Reactive Lyme serology in optic neuritis. J Neuroophthalmol 2005, 25:71–82.

    PubMed  Google Scholar 

  25. Jalladeau E, Pradat PF, Maisonobe T, Leger JM: Multiple mononeuropathy and inflammatory syndrome manifested in Lyme disease. Rev Neurol (Paris) 2001, 157:1290–1292.

    CAS  Google Scholar 

  26. Mormont E, Esselinckx W, De Ronde T, et al.: Abdominal wall weakness and lumboabdominal pain revealing neuroborreliosis: a report of three cases. Clin Rheumatol 2001, 20:447–450.

    Article  PubMed  CAS  Google Scholar 

  27. Gutknecht J, De Wazieres B, Fest T, Dupond JL: Guillain-Barré syndrome associated with Lyme disease. Presse Med 1994, 23:490.

    PubMed  CAS  Google Scholar 

  28. Shapiro EE: Guillain-Barré syndrome in a child with serologic evidence of Borrelia. Pediatr Infect Dis J 1998, 17:264–265.

    Article  PubMed  CAS  Google Scholar 

  29. England JD, Bohm RP, Roberts ED, Philipp MT: Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann Neurol 1997, 41:375–384.

    Article  PubMed  CAS  Google Scholar 

  30. Vallat JM, Hugon J, Lubeau M, et al.: Tick bite meningoradiculoneuritis. Neurology 1987, 37:749–753.

    PubMed  CAS  Google Scholar 

  31. Roberts ED, Bohm RP Jr, Lowrie RC Jr, et al.: Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis 1998, 178:722–732.

    Article  PubMed  CAS  Google Scholar 

  32. Holmgren AR, Matteson EL: Lyme myositis. Arthritis Rheum 2006, 54:2697–2700.

    Article  PubMed  Google Scholar 

  33. Karlsson M, Hammers S, Nilsson-Ehle I, et al.: Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis. Antimicrob Agents Chemother 1996, 40:1104–1107.

    PubMed  CAS  Google Scholar 

  34. Klempner M, Hu L, Evans J, et al.: Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001, 345:85–92.

    Article  PubMed  CAS  Google Scholar 

  35. Kaplan RF, Trevino RP, Johnson GM, et al.: Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurology 2003, 60:1916–1922.

    PubMed  CAS  Google Scholar 

  36. Krupp LB, Hyman LG, Grimson R, et al.: Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 2003, 60:1923–1930.

    PubMed  CAS  Google Scholar 

  37. Fallon B, Sackheim H, Keilp J, et al.: Double-blind placebo-controlled retreatment with IV ceftriaxone for Lyme encephalopathy: clinical outcome. In Proceedings of the 10th International Conference on Lyme Borreliosis and Other Tick-borne Diseases. Vienna, Austria; 2005:196.

  38. Halperin JJ: Treatment of Neuroborreliosis. Curr Treat Options Neurol 1999, 1:139–145.

    Article  PubMed  Google Scholar 

  39. Borg R, Dotevall L, Hagberg L, et al.: Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand J Infect Dis 2005, 37:449–454.

    Article  PubMed  CAS  Google Scholar 

  40. Dotevall L, Hagberg L: Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis 1999, 28:569–574.

    Article  PubMed  CAS  Google Scholar 

  41. Karkkonen K, Stiernstedt S, Karlsson M: Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis. Scand J Infect Dis 2001, 33:259–262.

    Article  PubMed  CAS  Google Scholar 

  42. Karlsson M, Hammers-Berggren S, Lindquist L, et al.: Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 1994, 44:1203–1207.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Atlantic Neuroscience Institute and New York University School of Medicine, Overlook Hospital, 99 Beauvoir Avenue, Summit, NJ, 07902, USA

    John J. Halperin

Authors
  1. John J. Halperin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John J. Halperin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Halperin, J.J. Diagnosis and treatment of the neuromuscular manifestations of Lyme disease. Curr Treat Options Neurol 9, 93–100 (2007). https://doi.org/10.1007/s11940-007-0035-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-007-0035-0

Keywords

Search

Navigation